Discovery of Novel Myc-Max Heterodimer Disruptors with a Three-Dimensional Pharmacophore Model

被引：66

作者：

Mustata, Gabriela ^{[1
]}

Follis, Ariele Viacava ^{[3
]}

Hammoudeh, Dalia I. ^{[3
]}

Metallo, Steven J. ^{[3
]}

Wang, Huabo ^{[4
,5
]}

Prochownik, Edward V. ^{[4
,5
]}

Lazo, John S. ^{[2
]}

Bahar, Ivet ^{[1
]}

机构：

[1] Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15260 USA

[2] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA

[3] Georgetown Univ, Dept Chem, Washington, DC 20057 USA

[4] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Hematol Oncol Sect, Pittsburgh, PA 15201 USA

[5] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA 15201 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 52卷 / 05期

关键词：

C-MYC; MYC/MAX DIMERIZATION; INHIBITION; GALAHAD;

D O I：

10.1021/jm801278g

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A three-dimensional pharmacophore model was generated utilizing a set of known inhibitors of c-Myc-Max heterodimer formation. The model successfully identified a set of structurally diverse compounds with potential inhibitory activity against c-Myc. Nine compounds were tested in vitro. and four displayed affinities in the micromolar range and growth inhibitory activity against c-Myc-overexpressing cells. These studies demonstrate the applicability of pharmacophore modeling to the identification of novel and potentially more puissant inhibitors of the c-Myc oncoprotein.

引用

页码：1247 / 1250

页数：4

共 50 条

[1] Inchworm Stepping of Myc-Max Heterodimer Protein Diffusion Along DNA
Dai, Liqiang
Yu, Jin
BIOPHYSICAL JOURNAL, 2021, 120 (03) : 140A - 140A
[2] Inchworm stepping of Myc-Max heterodimer protein diffusion along DNA
Dai, Liqiang
Yu, Jin
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (01) : 97 - 103
[3] Three-Dimensional Pharmacophore Methods in Drug Discovery
Leach, Andrew R.
Gillet, Valerie J.
Lewis, Richard A.
Taylor, Robin
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (02) : 539 - 558
[4] FUNCTIONAL MYC-MAX HETERODIMER IS REQUIRED FOR ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS
BISSONNETTE, RP
MCGAHON, A
MAHBOUBI, A
GREEN, DR
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06): : 2413 - 2418
[5] A three-dimensional model of glioblastoma for discovery of novel therapeutics
Kriuchkovskaia, Viktoriia
Harley, Brendan A.
Riggins, Rebecca B.
CANCER RESEARCH, 2023, 83 (07)
[6] A Three-Dimensional Pharmacophore Model for IMPDH Inhibitors
Yang, Na
Wang, Jian
Li, Jian
Wang, Qing-He
Wang, Yu
Cheng, Mao-Sheng
CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (01) : 175 - 182
[7] Structure-guided screening of protein-protein interaction for the identification of Myc-Max heterodimer complex modulators
Bhowmick, Shovonlal
Roy, Kunal
Saha, Achintya
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (05): : 2204 - 2222
[8] Discovery of a Pyrazolopyridinone-Based MYC Inhibitor That Selectively Engages Intracellular c-MYC and Disrupts MYC-MAX Heterodimerization
Obisesan, Oluwatosin A.
Ofori, Samuel
Orobator, Owamagbe N.
Sharma, Himanshi
Groetecke, Emma
Awuah, Samuel G.
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (06) : 6233 - 6251
[9] EComputer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer
Carabet, Lavinia A.
Lallous, Nada
Leblanc, Eric
Ban, Fuqiang
Morin, Helene
Lawn, Sam
Ghaidi, Fariba
Lee, Joseph
Mills, Ian G.
Gleave, Martin E.
Rennie, Paul S.
Cherkasov, Artem
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 160 : 108 - 119
[10] A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors
Lu, I-Lin
Tsai, Keng-Chang
Chiang, Yi-Kun
Jiaang, Weir-Torn
Wu, Ssu-Hui
Mahindroo, Neeraj
Chien, Chia-Hui
Lee, Shiow-Ju
Chen, Xin
Chao, Yu-Sheng
Wu, Su-Ying
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (08) : 1603 - 1611

← 1 2 3 4 5 →